Jasper Therapeutics (JSPR) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.74
-1.54
-1.33
-1.13

Details

Expected EPS
-1.214887
Actual EPS
-1.13
Surprise EPS
0.08
Surprise Percent
+6.99%

Description

Jasper Therapeutics (JSPR) has reported earnings of -1.13 per share for Q4 2025.

0 Comments

Share your thoughts